Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Pabinger

Showing results (201-210 of 367) with videos related to

Pageof 37
Sort By:
Platelets|May 14, 2015
Association of platelet activation markers with cancer-associated venous thromboembolismJulia Riedl, Lena Hell, Alexandra Kaider, et al.
Annals of Hematology|October 29, 2010
Circulating procoagulant microparticles in cancer patientsJohannes Thaler, Cihan Ay, Harald Weinstabl, et al.
British Journal of Haematology|November 18, 2003
Is the determination of anti-beta2 glycoprotein I antibodies useful in patients with venous thromboembolism without the antiphospholipid syndrome?Kety Hsieh, Paul Knöbl, Claudia Rintelen, et al.
Thrombosis and Haemostasis|December 6, 2013
Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer. Results from the Vienna Cancer and Thrombosis Study (CATS)Julia Riedl, Alexandra Kaider, Eva-Maria Reitter, et al.
Biochemia Medica|September 14, 2017
Testing lupus anticoagulants in a real-life scenario - a retrospective cohort studyFranz Ratzinger, Tanja Panic, Helmuth Haslacher, et al.
Thrombosis and Haemostasis|October 21, 2016
Decreased platelet reactivity in patients with cancer is associated with high risk of venous thromboembolism and poor prognosisJulia Riedl, Alexandra Kaider, Christine Marosi, et al.
Journal of Thrombosis and Haemostasis : JTH|June 24, 2022
Extracellular vesicles from amniotic fluid, milk, saliva, and urine expose complexes of tissue factor and activated factor VIIYong Hu, Andreas Repa, Ton Lisman, et al.
Critical Care Medicine|April 10, 2002
Frequent development of lupus anticoagulants in critically ill patients treated under intensive care conditionsCatharina Wenzel, Brigitte Stoiser, Gottfried J Locker, et al.
Journal of Thrombosis and Haemostasis : JTH|May 18, 2019
Association of complete blood count parameters, d-dimer, and soluble P-selectin with risk of arterial thromboembolism in patients with cancerElla Grilz, Christine Marosi, Oliver Königsbrügge, et al.
European Heart Journal|March 26, 2021
Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysisElla Grilz, Florian Posch, Stephan Nopp, et al.
Pageof 37

Showing results (201-210 of 367) with videos related to

Sort By:
Pageof 37
Platelets|May 14, 2015
Association of platelet activation markers with cancer-associated venous thromboembolismJulia Riedl, Lena Hell, Alexandra Kaider, et al.
Annals of Hematology|October 29, 2010
Circulating procoagulant microparticles in cancer patientsJohannes Thaler, Cihan Ay, Harald Weinstabl, et al.
British Journal of Haematology|November 18, 2003
Is the determination of anti-beta2 glycoprotein I antibodies useful in patients with venous thromboembolism without the antiphospholipid syndrome?Kety Hsieh, Paul Knöbl, Claudia Rintelen, et al.
Thrombosis and Haemostasis|December 6, 2013
Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer. Results from the Vienna Cancer and Thrombosis Study (CATS)Julia Riedl, Alexandra Kaider, Eva-Maria Reitter, et al.
Biochemia Medica|September 14, 2017
Testing lupus anticoagulants in a real-life scenario - a retrospective cohort studyFranz Ratzinger, Tanja Panic, Helmuth Haslacher, et al.
Thrombosis and Haemostasis|October 21, 2016
Decreased platelet reactivity in patients with cancer is associated with high risk of venous thromboembolism and poor prognosisJulia Riedl, Alexandra Kaider, Christine Marosi, et al.
Journal of Thrombosis and Haemostasis : JTH|June 24, 2022
Extracellular vesicles from amniotic fluid, milk, saliva, and urine expose complexes of tissue factor and activated factor VIIYong Hu, Andreas Repa, Ton Lisman, et al.
Critical Care Medicine|April 10, 2002
Frequent development of lupus anticoagulants in critically ill patients treated under intensive care conditionsCatharina Wenzel, Brigitte Stoiser, Gottfried J Locker, et al.
Journal of Thrombosis and Haemostasis : JTH|May 18, 2019
Association of complete blood count parameters, d-dimer, and soluble P-selectin with risk of arterial thromboembolism in patients with cancerElla Grilz, Christine Marosi, Oliver Königsbrügge, et al.
European Heart Journal|March 26, 2021
Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysisElla Grilz, Florian Posch, Stephan Nopp, et al.
Pageof 37